Riskpilot← Back to searchSign inGet full accessOlink Proteomics AB
ABActiveOrg 5590468632Dag Hammarskjölds Väg 52 BResearch and experimental development on natural sciences and engineering · NACE 7210Est. 2016394 employees
Revenue 2024
SEK 1,4B
-6% vs 2023
EBITDA margin
-38.2%
-701% vs 2023
Equity ratio
65.7%
Financial strength
Net profit 2024
SEK -479,9M
-594% vs 2023
| Revenue | SEK 1,4B | -6% |
| EBITDA | SEK -527,7M | -701% |
| Net profit | SEK -479,9M | -594% |
| Total assets | SEK 1,7B | -10% |
| Equity | SEK 1,1B | -30% |
| Employees | 394 | — |
Legal name
Olink Proteomics AB
Org number
5590468632
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
13 januari 2016
Share capital
SEK 50 000
Employees
394 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Liminga Björk, Eva Maria Monster, Bram Verhoosel, Michel van der Zande, Petrus Thomas Adrianus
Company purpose
Bolaget skall bedriva utveckling, produktion, marknadsföring och försäljning av bioteknologiska produkter och tjänster och därmed förenlig verksamhet.
Address
Dag Hammarskjölds Väg 52 B
Phone
+46184443970
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 322 275 | 473 665 | 491 815 | 780 087 | 1 357 752 | 1 473 511 | 1 382 259 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | −13 376 | 86 346 | 80 888 | 69 314 | 29 650 | −91 919 | −13 463 | −65 890 | −527 747 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — |
| EBIT | −13 376 | 86 346 | 80 888 | 69 314 | 29 650 | −91 919 | −13 463 | −65 890 | −527 747 |
| Net financials | 3 066 | 449 | 2 261 | 1 066 | −7 162 | 6 022 | 18 046 | −38 736 | 11 585 |
| Profit before tax | −10 310 | 4 306 | 62 735 | 52 289 | −544 | −34 892 | 4 584 | −90 059 | −614 361 |
| Tax | −0 | −0 | −12 598 | −11 253 | −0 | 6 538 | −298 | 20 938 | 134 467 |
| Net profit | −10 310 | 4 306 | 50 137 | 41 036 | −544 | −28 354 | 4 286 | −69 121 | −479 894 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 91 465 | 100 764 | 219 940 | 352 688 | 677 352 | 1 020 734 | 1 256 042 | 1 875 073 | 1 690 919 |
| Equity | 69 401 | 73 708 | 123 845 | 238 830 | 401 931 | 373 577 | 377 864 | 1 591 274 | 1 111 379 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 22 064 | 27 056 | 75 681 | 75 353 | 236 916 | 647 156 | 878 178 | 283 799 | 579 540 |
| Total debt | 22 064 | 27 056 | 75 681 | 75 353 | 236 916 | 647 156 | 878 178 | 283 799 | 579 540 |
EBITDA margin
-38.2%
This company
15.8%
Market median
-342% vs market
20162024
Equity ratio
65.7%
This company
38.2%
Market median
+72% vs market
20162024
Return on equity
-43.2%
This company
18.4%
Market median
-335% vs market
20162024
Net profit margin
-34.7%
This company
8.1%
Market median
-528% vs market
20162024
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20162024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EM Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
LM Chief Auditor | Chief Auditor | 2025 | — | — |
AM Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
FO Chief Auditor | Chief Auditor | 2022 | — | — |
EE Authorized Recipient of Service | Authorized Recipient of Service | 2026 | — | — |
JM Chief Auditor | Chief Auditor | 2024 | — | — |
PJ Chief Auditor | Chief Auditor | 2021 | — | — |
KL Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2024 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Olink Holding Ab (Publ) | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
THERMO FISCHER SCIENTIFIC INCOrion Acquisition ABOlink Holding Ab (Publ)
Olink Proteomics AB (this company)Olink Proteomics B.V.Olink Proteomics Sg Pte LtdOlink Proteomics LtdOlink Proteomics IncOlink Proteomics SasOlink Proteomics KkOlink Bioscience Co LtdOlink Proteomics GmbhOLINK PROTEOMICS SASOLINK PROTEOMICS SG PTE LTDOLINK PROTEOMICS B.V.OLINK PROTEOMICS KKOLINK PROTEOMICS GMBHOLINK PROTEOMICS INCOLINK BIOSCIENCE CO LTDOLINK PROTEOMICS LTDBoard members of Olink Proteomics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Maria Liminga Björk | Chief Executive Officer | 0 companies |
| Lina Maria Josefine Jernebring | Chief Auditor | 0 companies |
| Anna Maria Marsell | Chief Executive Officer | 0 companies |
| Fredrik Oskar Norrman | Chief Auditor | 0 companies |
| Elias Ego | Authorized Recipient of Service | 0 companies |
| Jakob Marek Wojcik | Chief Auditor | 0 companies |
| Per Johan Engstam | Chief Auditor | 0 companies |
| Karl Leonard Daun | Chief Auditor | 0 companies |
| Bram Monster | Board of Directors | 0 companies |
| Rickard El Tarzi | Chairman | 0 companies |
| Johan Magnus Lyth | Board of Directors | 0 companies |
| Tommy Mattias Jansson | Board of Directors | 0 companies |
| Jon Aron Olof Heimer | Chairman | 0 companies |
| Anthony Hugh Smith | Chairman | 0 companies |
| Petrus Thomas Adrianus van der Zande | Chairman | 0 companies |
| Gustaf Oskar Hjelm | Chairman | 0 companies |
| Per Magnus Eriksson | Deputy Board Member | 0 companies |
| Michel Verhoosel | Board of Directors | 0 companies |
| Tommi Markus Unkuri | Chairman | 0 companies |